9th
Congress of the European Society of Contraception
| Final
programme in detail |
|||
| Wednesday,
May 3 |
Thursday,
May 4 |
Friday,
May 5 |
Saturday,
May 6 |
overview>>>
| 08:30 – 10:00 | 10:30
– 12:00 |
12:00 –
14:30 |
14:30 –
16:00 |
16:30 – 18:00 |
| 10:30 –
12:00 |
Sponsored
Symposium 3 (Organon) NuvaRing® — From Science to Satisfaction |
|
| Chair: C. Benedetto (Italy), Co-chair: B.
Oddens (The Netherlands) |
||
| 10:30 • SS3-01 | Scientific backbone – paradigm
shift from dose to exposure E. Ng (USA) |
|
| 10:55 • SS3-02 | A balancing act – I. Milsom (Sweden) | |
| 11:20 • SS3-03 | Providing a logical choice for your
patient – R. Nappi (Italy) |
|
|
||
| 10:30 –
12:00 |
Session
4 (State of the Art) Attitudes to contraception |
|
| Chair: T. Sener (Turkey), Co-chair: A.
Yeshaya (Israel) |
||
| 10:30 • IS-17 | Religion and traditions – B.
Dilbaz (Turkey) |
|
| 10:50 • IS-18 | Media issues, educational framework
– D. Apter (Finland) |
|
| 11:10 • IS-19 | Educational and legal framework –
G. Lazdane (WHO) |
|
| Free communications | ||
| 11:30 • FC-28 | University student men’s views,
attitudes and behaviours about family planning and emergency contraception – H. Sahin (Turkey) |
|
| 11:45 • FC-29 | Reproductive Health Education of
Conscripts Armed Forces: First Evaluation of Training Courses. (in Turkish) S. Gungor (Turkey) |
|
|
|
||
| 10:30 –
12:00 |
Free
Communication Session 4 |
|
| Chair: A. Bigrigg (UK), Co-chair: D.
Rebelo (Portugal) |
||
| 10:30 • FC-30 | The Challenges of Unprotected Sex:
Statistical Analysis of a Global Sex Survey – M.B.F. Fontes (USA) |
|
| 10:43 • FC-31 | Significant improvement in
cycle-related symptoms following treatment with continuous LNG/EE, a low-dose continuous oral contraceptive. – E.W. Freeman (USA) |
|
| 10:56 • FC-32 | Prevalence of bacterial vaginosis and
relationship with personal hygiene in Turkish women using an IUD – I. Gonenc (Turkey) |
|
| 11:09 • FC-33 | Identification of novel endometrial
targets for contraception using microarray technology – S. Mirkin (USA) |
|
| 11:22 • FC-34 | Evaluation of the benefits of a new
hysteroscopic sterilisation (Essure®) on the OPD. – M.P.H. Vleugels (The Netherlands) |
|
| 11:35 • FC-35 | Ease and safety of insertion,
contraceptive performance and effect on menstrual blood loss of a new LNG-IUS, FemilisTM, in parous and nulliparous women – D. Wildemeersch (Belgium) |
|
| 11:48 • FC-36 | The poor knowledge on contraceptive
methods is major cause of induced abortion leading to infectious abortion in women of west areas in Iran – R. Ahmadi (Iran) |
|
|
|
||
| 10:30 –
12:00 |
A |
European
Society for Human Reproduction and Embryology (ESHRE) |
| Hormonal
contraception and cardiovascular risk |
||
| Chair: P.G. Crosignani (Italy), Co-chair:
D. Cibula (Czech Rep.) |
||
| 10:30 | Coronary heart and cardiovascular
disease – C. La Vecchia (Italy) |
|
| 11:00 | The metabolic syndrome – A. J.
Goverde (The Netherlands) |
|
| 11:30 | Hormonal contraception in PCO patients
– D. Cibula (Czech Rep.) |
|
|
|
| Final
programme in detail |
|||
| Wednesday,
May 3 |
Thursday,
May 4 |
Friday,
May 5 |
Saturday,
May 6 |
| 08:30 – 10:00 | 10:30
– 12:00 |
12:00 –
14:30 |
14:30 –
16:00 |
16:30 – 18:00 |
|
complete final programme(306 kB) |
|
